Statistics for Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia
Total visits
| views | |
|---|---|
| Sustained Efficacy and Safety of Burosumab, a Monoclonal Antibody to FGF23, in Children With X-Linked Hypophosphatemia | 40 |
Total visits per month
| views | |
|---|---|
| January 2024 | 0 |
| February 2024 | 0 |
| March 2024 | 0 |
| April 2024 | 0 |
| May 2024 | 0 |
| June 2024 | 0 |
| July 2024 | 0 |
Top country views
| views | |
|---|---|
| United States | 36 |
Top city views
| views | |
|---|---|
| Wilmington | 29 |
| Baltimore | 2 |
| Fairfield | 2 |
| Washington | 2 |
| Ann Arbor | 1 |